Evaluating the Implementation and Impact of BRAF Reflex Mutation Testing in Melanoma, Lung, and Colorectal Cancers
This study underscores the success of the pathology team at MUHC in implementing reflex <i>BRAF</i> mutation testing, enhancing clinical care by ensuring the timely availability of test results. Delays in testing may adversely affect clinical decision-making and therapy selection, highlighting the need for standardized reflex testing protocols across Canada to optimize patient outcomes in melanoma, lung, and colorectal cancers.
Authors
- Daniel Josué Guerra Ordaz
- Amina Moustaqim‐Barrette (ORCID: https://orcid.org/0000-0003-1601-1604)
- Sera Whitelaw
- Ivan V. Litvinov (ORCID: https://orcid.org/0000-0003-0562-4675)
- Mohammed Kaouache (ORCID: https://orcid.org/0000-0003-0876-047X)
- Louise Gresham (ORCID: https://orcid.org/0000-0001-8614-1776)
- Brandon Ramchatesingh
- Margaret Redpath
- May Chergui
Institutions
- McGill University Health Centre (CA)
- Jewish General Hospital (CA)
- McGill University (CA)
Publication Details
- Journal
- Journal of Cutaneous Medicine and Surgery
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1177/12034754241302821
- Primary Topic
- Melanoma and MAPK Pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canadian Institutes of Health Research
- Fonds de Recherche du Québec - Santé